经颅磁刺激作为严重视网膜退行性疾病新型治疗方法的初步研究
这项前瞻性、非随机、平行组预试验纳入98例双侧严重近视性黄斑变性(MMD)或视网膜色素变性(RP)患者,比较连续5天θ爆发式经颅磁刺激(TMS)与常规保守治疗。分析88例患者174只眼,TMS组在4周随访时BCVA和视野平均缺损较对照组改善更明显,对比敏感度、黄斑敏感度和固视稳定性也有短期增益,fMRI显示视觉相关皮层活动及功能连接增加。
要点
- TMS组MMD患者BCVA改善0.22±0.28 logMAR,RP患者改善0.24±0.21 logMAR。
- TMS组MMD视野平均缺损改善1.96±2.09 dB,RP改善1.08±1.28 dB。
- fMRI显示TMS后视觉相关皮层区域活动及功能连接增加。
核心结论
- 在这项探索性预试验中,TMS治疗与严重视网膜退行性疾病患者短期功能性视力改善及皮层调节相关。
- 这些发现具有假设生成性,需通过更大规模、随机、设盲、更长随访的临床试验验证。
研究设计与样本
- 前瞻性、非随机、平行组预试验,纳入98例双侧严重MMD或RP患者。
- 参与者接受连续5天θ爆发式TMS或常规保守治疗,主要结局为基线至4周随访BCVA和视野变化。
- 分析88例患者174只眼,平均年龄60.3±9.1岁,52%为女性。
主要发现
- 与对照组相比,TMS组BCVA改善更明显:MMD为0.22±0.28 logMAR,RP为0.24±0.21 logMAR。
- 与对照组相比,TMS组视野平均缺损改善更明显:MMD为1.96±2.09 dB,RP为1.08±1.28 dB。
- 对比敏感度、黄斑敏感度和固视稳定性也显示短期增益。
- 患者报告结局在多个功能领域改善。
- fMRI显示TMS后视觉相关皮层区域活动及功能连接增加。
临床怎么用
- 结果支持TMS作为严重视网膜退行性疾病潜在康复手段的探索方向,但当前证据尚不足以支持临床常规开展。
- 临床决策时应向患者说明该干预仍处于预试验阶段,需等待更大规模随机设盲试验验证。
局限性
- 为非随机、平行组预试验,作者指出发现具有假设生成性,需更大规模、随机、设盲、更长随访的临床试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Retinal degenerative diseases, including myopic macular degeneration (MMD) and retinitis pigmentosa (RP), lead to irreversible vision impairment, with limited treatment options. Transcranial magnetic stimulation (TMS), a non-invasive brain stimulation technique for rehabilitation, may hold potential for vision restoration. The pilot study explored whether TMS is associated with short-term functional visual improvements in patients with severe retinal degenerative diseases. METHODS: This prospective, non-randomised, parallel-arm pilot study enrolled 98 patients with bilateral severe MMD or RP. Participants received either five consecutive days of theta-burst TMS or conventional conservative care. Primary outcomes were changes in best-corrected visual acuity (BCVA) and visual field from baseline to 4-week follow-up. Contrast sensitivity, macular sensitivity, fixation stability, Visual Function Index-14 (VF-14) and Visual Functioning Questionnaire-25 (VFQ-25) questionnaires were also evaluated. A subset of participants underwent resting-state functional magnetic resonance imaging (fMRI) to explore cortical functional changes. RESULTS: The study analysed 174 eyes from 88 patients (mean age: 60.3±9.1 years; 52% female). Compared with controls, the TMS group showed greater improvements in BCVA (MMD: 0.22±0.28 logarithm of the minimum angle of resolution (logMAR); RP: 0.24±0.21 logMAR) and VF mean defect (MMD: 1.96±2.09 dB; RP: 1.08±1.28 dB). Contrast sensitivity, macular sensitivity and fixation stability also showed short-term gains. Patient-reported outcomes improved in several functional domains. fMRI demonstrated increased activity and functional connectivity in visual-related cortical regions following TMS. CONCLUSIONS: In this exploratory pilot study, TMS treatment was associated with short-term functional visual improvements and cortical modulation in individuals with severe retinal degenerative diseases. These findings are hypothesis-generating and warrant validation through larger, randomised, masked clinical trials with longer follow-up.
引用
- Meng J, Zhang Y, Pei Y, et al. Transcranial magnetic stimulation as a novel therapeutic approach for severe retinal degenerative diseases: a pilot study. Br J Ophthalmol. 2026. PMID: 42538141. doi:10.1136/bjo-2025-329114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。